The fatality risk-money tradeoff that is the value of a statistical life (VSL) may vary with the nature of the fatality event. While all fatalities involve loss of future life expectancy, the morbidity effects and their duration may differ. This article analyzes fatality risks accompanied by...

Policy applications of the value of a statistical life (VSL) often make a benefits transfer assumption that the VSL from one market context is broadly applicable to other contexts as in the U.S. Dept. of Transportation’s estimate of $9.1 million based on labor market estimates of VSL. This...

Many regulatory agencies have authority to promptly protect against grave dangers—so long as the danger is not too grave, according to recent Supreme Court jurisprudence. Agencies are often delegated emergency authority to address risks rapidly, though temporarily, to protect the public from...

Prescription drug use is a risky endeavor. These risks are rarely precisely known, and patients may react to this ambiguity in unpredictable ways. Patient perceptions of ambiguous drug risks are difficult to elicit from market data. This paper uses an incentivized experiment to explore the...